|
|
|
|
|
|
|
Clinical Case-Based Learning Educational Program |
|
|
|
|
|
| Tumor Board Reviewing PSMA PET In The Care of Patient with Gleason 4+5=9, GG 5 Prostate Adenocarcinoma, with an Intraductal Component, Session 1 Case 1
|
| Alicia Morgans, MD, MPH, Heather Jacene, MD, Paul Nguyen, MD, and Adam Kibel, MD
|
| In this Clinical Case-Based Learning Educational Program, a Virtual Tumor Board in Prostate Cancer, a case of a 76-year-old man with a history of hypertension and an active lifestyle is presented, evaluated, and his treatment plan addressed.
|
|
|
|
|
|
|
|
|
|
|
|
| Tumor Board Reviewing the Use of PSMA PET in Patient with Gleason Gleason 3+4=7 with MLH1 Pathogenic Mutation Prostate Adenocarcinoma - Session 1 Case 2 |
| Alicia Morgans, MD, MPH, Heather Jacene, MD, Paul Nguyen, MD, and Adam Kibel, MD
|
| In this Clinical Case-Based Learning Educational Program, a Virtual Tumor Board in Prostate Cancer, a case of a 66 year old man with a history of hypertension and hypercholesterolemia is presented, evaluated, and his treatment plan addressed. |
|
|
|
|
|
|
|
|
|
|
|
| Tumor Board Reviewing the Use of PSMA PET in the Care of Patient with Gleason 3+4=7 GG 2, 3 Cores on Right, 6 Negative Cores Prostate Adenocarcinoma - Session 1 Case 3 |
| Alicia Morgans, MD, MPH, Heather Jacene, MD, Paul Nguyen, MD, and Adam Kibel, MD
|
| In this Clinical Case-Based Learning Educational Program, a Virtual Tumor Board in Prostate Cancer, a case of a 69-year-old man with a history of Crohn's disease that's under control, arthritis, chronic HCV, hypertension, and non-muscle-invasive bladder cancer is presented, evaluated, and his treatment plan addressed. |
|
|
|
|
|
|
|
|
|
|
|
| Tumor Board Reviewing PSMA PET In The Care of Patient with Gleason 4+4=8 GG 4, 6 Cores on Left, Gleason 4+3=7 GG, 6 Cores on Right Prostate Adenocarcinoma, Session 1 Case 4
|
| Alicia Morgans, MD, MPH, Heather Jacene, MD, Paul Nguyen, MD, and Adam Kibel, MD
|
| In this Clinical Case-Based Learning Educational Program, a Virtual Tumor Board in Prostate Cancer, a case of a 68-year-old man is presented, evaluated, and his prostate cancer treatment plan is addressed.
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
